Skip to Main Content

We publish recommendations and resources, together with a host of other material for the benefit of our users.

SPS PGD template for the supply and/or administration of subcutaneous medroxyprogesterone acetate (SC-DMPA) injection for contraception.
SPS protocol templates for the supply and administration of omeprazole for caesarean section by registered midwives.
PGD and VGD templates by UKHSA are developed for a range of clinical scenarios. A summary of the processes to use and further links are provided.
SPS PGD template for supply of doxycycline for the treatment of uncomplicated genital chlamydia trachomatis, LGV and non-gonococcal/non-specific urethritis.
Advice on the use of Patient Group Directions (PGDs) to supply or administer a medication which is part of a clinical trial, study or pilot
E-learning developed by SPS in partnership with UKHSA, HEE and eLfH to support professionals who use, develop, authorise, review or update PGDs.
SPS PGD template for administering benzylpenicillin prior to transfer to secondary care in suspected bacterial meningitis or meningococcal septicaemia.
A resource collating the latest medication safety communications and publications to inform, support and inspire medication safety improvements.
SPS PGD template for supply of azithromycin for uncomplicated genital Chlamydia trachomatis, non-gonococcal/non-specific urethritis; Mycoplasma genitalium.
The SPS National Medicines Governance Do Once programme produce national Patient Group Direction (PGD) exemplar templates for local adaptation
The availability of epidural bags will fluctuate over the coming weeks and months. See the current list of available products which will be updated regularly.
Resources, guidance and support to assess and improve medication safety culture, strategy and policy within the healthcare system.
Resources, guidance and support to assess and improve medication safety culture, strategy and policy within the healthcare system.
Suggested resources to help healthcare professionals find information regarding the use of medicines in renal impairment
Resources, guidance and support to assess and improve medication safety culture, strategy and policy within the healthcare system.
Information should be gathered about the renal impairment history or type of kidney disease to enable a risk assessment and decisions about treatment.
The process requires care and continual review. You should plan, discuss and agree a shared strategy with the patient.
Before undertaking antidepressant withdrawal, you should plan, discuss and agree a shared strategy with the patient.
A resource collating the latest medication safety communications and publications to inform, support and inspire medication safety improvements.
Know what medicines are in the pipeline. Understand the strategic and operational challenges for the NHS. Start planning early.
New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.
Effective use provides assurance that an organisation is aware of the most critical medication safety related information, and acts on this to improve safety
Advice on the use of Patient Group Directions (PGDs) to supply or administer a medication which is part of a clinical trial, study or pilot
E-learning developed by SPS in partnership with UKHSA, HEE and eLfH to support professionals who use, develop, authorise, review or update PGDs.
A report on the state of the pharmacy technical services workforce in the North of England
A checklist for audits and self-inspections for the holders of wholesale distribution authorisations
SPS have developed a template audit tool to support organisations in auditing aspects of PGD development and use.